ABIN358170
antibody from antibodies-online
Targeting: NFKB1
KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358170 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (Avian) (RELA) (pSer536) antibody
- Antibody type
- Polyclonal
- Antigen
- V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (Avian) (RELA)
- Reactivity
- Human
- Host
- Rabbit
- Antigen sequence
This antibody is generated from rab
bits immunized with a KLH conjugate
d syntheticphosphopeptide correspon
ding to amino acid residues surroun
ding S536 of human NFKB.- Vial size
- 0.1 mg
- Concentration
- 0.25 mg/mL
Submitted references Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis.
HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation.
p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.
Zamora M, Meroño C, Viñas O, Mampel T
The Journal of biological chemistry 2004 Sep 10;279(37):38415-23
The Journal of biological chemistry 2004 Sep 10;279(37):38415-23
HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA
Blood 2004 Sep 1;104(5):1490-7
Blood 2004 Sep 1;104(5):1490-7
PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Jang HD, Yoon K, Shin YJ, Kim J, Lee SY
The Journal of biological chemistry 2004 Jun 4;279(23):24873-80
The Journal of biological chemistry 2004 Jun 4;279(23):24873-80
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation.
Yeh PY, Yeh KH, Chuang SE, Song YC, Cheng AL
The Journal of biological chemistry 2004 Jun 18;279(25):26143-8
The Journal of biological chemistry 2004 Jun 18;279(25):26143-8
p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.
Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC
The Journal of biological chemistry 2004 Jun 18;279(25):26115-25
The Journal of biological chemistry 2004 Jun 18;279(25):26115-25
No comments: Submit comment
No validations: Submit validation data